Data presented at SABCS indicates benefits of oral paclitaxel and encequidar (oral paclitaxel) versus IV paclitaxel (IVP) on Progression-Free Survival...
Expanding the patent estate for the lead clinical program to treat cancer anorexiaLA JOLLA, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE)...
ILUVIEN has been launched for both Diabetic Macular Edema and Non-Infectious Posterior Uveitis IndicationsATLANTA, Dec. 09, 2020 (GLOBE NEWSWIRE) --...
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence...
NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical...
Patient enrollment completion anticipated by the end of April 2021InFoods® Diagnostic-Guided Therapy is designed to address the $30 billion market...
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for...
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been...
REDWOOD CITY, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company,...
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
Dr. Kevin A. Carter Appointed to Board of DirectorsCINCINNATI, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech”...
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of...
Presentations highlight lumateperone’s broad antidepressant effects in patients with bipolar disorder and in patients with schizophrenia with co-morbid depression NEW...
ImmunoGenesis acquires rights to evofosfamide; Phase 2 clinical testing in combination with checkpoint blockade is planned for 2021.Evofosfamide is the only...
Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more...
Increases Size of Facility and Extends Interest-Only Period Enabling ADMA to Reach Profitability Prior to Maturity Demonstrates Perceptive’s Commitment and...
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Tongji Healthcare Group, Inc. (OTCMKTS:TONJ) (Name Change to “Clubhouse...
Please read the full announcement in PDF Attachment 2020_63_Proposal_of_candidates_to_the_Board_of_Directors
PepGen’s proprietary cell-penetrating peptide technology promises enhanced safety, efficacy, and improved delivery to cardiac muscle; Oxford Sciences Innovation, The University...